Levetiracetam Wockhardt

Levetiracetam, the active ingredient in Levetiracetam Wockhardt, is an Antiepileptic presented as a tablet for oral use. It is employed to treat partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Wockhardt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizure activity.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: decreases the occurrence of rapid muscle jerks.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Severe depression or mood changes - Rash or skin eruptions - Blood dyscrasias such as neutropenia

When prescribing Levetiracetam, clinicians should consider several safety aspects.

Renal function: adjust dosage in patients with impaired renal clearance. Hepatic function: monitor liver enzymes in patients with liver disease. Pregnancy: potential risks are unknown; discuss benefits and risks with the prescriber. Concomitant CNS depressants: may increase sedation and impair alertness. Driving and operating machinery: patients should be cautioned about possible drowsiness. Store at room temperature: keep in the original container, protect from moisture and heat.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: may reduce levetiracetam concentrations. - Phenobarbital: can decrease levetiracetam exposure. - Alcohol: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of adverse effects. - Other CNS‑active drugs: monitor for enhanced sedation. - Fluoroquinolone antibiotics: may raise seizure risk.